These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34560064)

  • 1. The Inducible Nitric Oxide Synthase Pathway Promotes Osteoclastogenesis under Hypoxic Culture Conditions.
    Kondo T; Otsuka Y; Aoki H; Goto Y; Kawaguchi Y; Waguri-Nagaya Y; Miyazawa K; Goto S; Aoyama M
    Am J Pathol; 2021 Dec; 191(12):2072-2079. PubMed ID: 34560064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor stimulates osteoclastogenesis from human bone marrow cells under hypoxic conditions.
    Nomura T; Aoyama M; Waguri-Nagaya Y; Goto Y; Suzuki M; Miyazawa K; Asai K; Goto S
    Exp Cell Res; 2014 Feb; 321(2):167-77. PubMed ID: 24360989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption.
    Zheng H; Yu X; Collin-Osdoby P; Osdoby P
    J Biol Chem; 2006 Jun; 281(23):15809-20. PubMed ID: 16613848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J; Jing Z; Hu W; Yu J; Cui X
    Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β promotes osteoclastogenesis by increasing the expression of IGF2 and chemokines in non-osteoclastic cells.
    Otsuka Y; Kondo T; Aoki H; Goto Y; Kawaguchi Y; Waguri-Nagaya Y; Miyazawa K; Goto S; Aoyama M
    J Pharmacol Sci; 2023 Jan; 151(1):1-8. PubMed ID: 36522118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis.
    Collin-Osdoby P; Rothe L; Bekker S; Anderson F; Osdoby P
    J Bone Miner Res; 2000 Mar; 15(3):474-88. PubMed ID: 10750562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats.
    Herrera BS; Martins-Porto R; Maia-Dantas A; Campi P; Spolidorio LC; Costa SK; Van Dyke TE; Gyurko R; Muscara MN
    J Periodontol; 2011 Nov; 82(11):1608-15. PubMed ID: 21417589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide (LPS) stimulates the production of tumor necrosis factor (TNF)-alpha and expression of inducible nitric oxide synthase (iNOS) by osteoclasts (OCL) in murine bone marrow cell culture.
    Kikkawa I; Saito S; Tominaga K; Hoshino Y; Ooi Y; Nakano M
    Microbiol Immunol; 1998; 42(9):591-8. PubMed ID: 9802559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts.
    Amend SR; Uluckan O; Hurchla M; Leib D; Novack DV; Silva M; Frazier W; Weilbaecher KN
    J Bone Miner Res; 2015 Jan; 30(1):106-15. PubMed ID: 25042340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-GEF trio regulates osteoclast differentiation and function by Rac1/Cdc42.
    Gu J; Yang Z; Yuan L; Guo S; Wang D; Zhao N; Meng L; Liu H; Chen W; Ma J
    Exp Cell Res; 2020 Nov; 396(1):112265. PubMed ID: 32898553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways.
    Hama M; Kirino Y; Takeno M; Takase K; Miyazaki T; Yoshimi R; Ueda A; Itoh-Nakadai A; Muto A; Igarashi K; Ishigatsubo Y
    Arthritis Rheum; 2012 May; 64(5):1518-28. PubMed ID: 22127667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts.
    Lin SK; Kok SH; Kuo MY; Lee MS; Wang CC; Lan WH; Hsiao M; Goldring SR; Hong CY
    J Bone Miner Res; 2003 Jan; 18(1):39-46. PubMed ID: 12510804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis.
    Gorissen B; de Bruin A; Miranda-Bedate A; Korthagen N; Wolschrijn C; de Vries TJ; van Weeren R; Tryfonidou MA
    J Cell Physiol; 2018 Jan; 234(1):414-426. PubMed ID: 29932209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
    Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
    Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligustilide suppresses RANKL-induced osteoclastogenesis and bone resorption via inhibition of RANK expression.
    Wang D; Li J; Feng W; Yao J; Ou L; Liao S; Liu Y; Li B; Lin C; Zhao J; Zhao G
    J Cell Biochem; 2019 Nov; 120(11):18667-18677. PubMed ID: 31436338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor 2 promotes osteoclastogenesis increasing inflammatory cytokine levels under hypoxia.
    Kondo T; Aoki H; Otsuka Y; Kawaguchi Y; Waguri-Nagaya Y; Aoyama M
    J Pharmacol Sci; 2022 Jul; 149(3):93-99. PubMed ID: 35641033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4
    Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
    Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.